Lupin recalls 26,352 bottles of Rifampin Capsules in US market

10 Apr 2024 Evaluate

Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market. The affected lot has been produced by the drug firm at its Aurangabad-based facility and marketed in the American market by its Baltimore-based unit Lupin Pharmaceuticals, Inc.

As per the US Food and Drug Administration (USFDA), the company is recalling the lot for being ‘Subpotent’. The company issued the Class II recall on March 21 this year.  

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

1656.70 19.15 (1.17%)
30-Apr-2024 10:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1519.00
Dr. Reddys Lab 6285.50
Cipla 1413.20
Zydus Lifesciences 958.85
Lupin 1656.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.